About Jagsonpal
Jagsonpal is a company based in Delhi (India) founded in 1964. The company has 1,410 employees as of March 31, 2024. Jagsonpal has completed 1 acquisition, including Yash Pharma. Jagsonpal operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Delhi, India
- Employees 1410 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jagsonpal Pharmaceuticals Ltd.
-
Annual Revenue
$31.49 M (USD)28.76as on Mar 31, 2025
-
Net Profit
$6.48 M (USD)146.45as on Mar 31, 2025
-
EBITDA
$6.05 M (USD)118.18as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
1410
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Jagsonpal
Jagsonpal is a publicly listed company on the NSE with ticker symbol JAGSNPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Jagsonpal
Unlock access to complete
Unlock access to complete
Funding Insights of Jagsonpal
Investments & Acquisitions by Jagsonpal
Jagsonpal has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Yash Pharma.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Architect providing design and construction services for residential projects
|
1972 |
Financial Statements - Jagsonpal
Jagsonpal Comparisons
Competitors of Jagsonpal
Jagsonpal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
Latest news on Jagsonpal
Frequently Asked Questions about Jagsonpal
Jagsonpal was founded in 1964.
Jagsonpal is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Parveen Kaushal is the current CEO of Jagsonpal.
As of Mar 31, 2024, the latest employee count at Jagsonpal is 1,410.
Annual revenue of Jagsonpal is $31.49M as on Mar 31, 2025.
Jagsonpal was established in 1964 as a pharmaceutical entity focused on bulk drugs and finished formulations. A portfolio of 9 active pharmaceutical ingredients and over 200 formulation products is maintained. Operations span 13 countries across three continents, in addition to India. Contract manufacturing services are primarily provided to other pharmaceutical firms. The company is headquartered in Delhi, India.
Jagsonpal's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Yes, Jagsonpal is publicly traded on NSE under the ticker symbol JAGSNPHARM.
Jagsonpal has made 1 acquisition, including Yash Pharma.
The ticker symbol of Jagsonpal is JAGSNPHARM on NSE.